Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory, 7925 Cape Town, South Africa.
Virol J. 2012 Aug 16;9:164. doi: 10.1186/1743-422X-9-164.
Human papillomavirus (HPV) is the aetiological agent for cervical cancer and genital warts. Concurrent HPV and HIV infection in the South African population is high. HIV positive (+) women are often infected with multiple, rare and undetermined HPV types. Data on HPV incidence and genotype distribution are based on commercial HPV detection kits, but these kits may not detect all HPV types in HIV + women. The objectives of this study were to (i) identify the HPV types not detected by commercial genotyping kits present in a cervical specimen from an HIV positive South African woman using next generation sequencing, and (ii) determine if these types were prevalent in a cohort of HIV-infected South African women.
Total DNA was isolated from 109 cervical specimens from South African HIV + women. A specimen within this cohort representing a complex multiple HPV infection, with 12 HPV genotypes detected by the Roche Linear Array HPV genotyping (LA) kit, was selected for next generation sequencing analysis. All HPV types present in this cervical specimen were identified by Illumina sequencing of the extracted DNA following rolling circle amplification. The prevalence of the HPV types identified by sequencing, but not included in the Roche LA, was then determined in the 109 HIV positive South African women by type-specific PCR.
Illumina sequencing identified a total of 16 HPV genotypes in the selected specimen, with four genotypes (HPV-30, 74, 86 and 90) not included in the commercial kit. The prevalence's of HPV-30, 74, 86 and 90 in 109 HIV positive South African women were found to be 14.6%, 12.8%, 4.6% and 8.3% respectively.
Our results indicate that there are HPV types, with substantial prevalence, in HIV positive women not being detected in molecular epidemiology studies using commercial kits. The significance of these types in relation to cervical disease remains to be investigated.
人乳头瘤病毒(HPV)是宫颈癌和生殖器疣的病因。南非人群中同时感染 HPV 和 HIV 的情况很高。HIV 阳性(+)的女性通常感染多种罕见和未确定的 HPV 类型。HPV 发病率和基因型分布的数据基于商业 HPV 检测试剂盒,但这些试剂盒可能无法检测到 HIV + 女性中的所有 HPV 类型。本研究的目的是:(i)使用下一代测序技术识别来自南非 HIV 阳性女性宫颈标本中商业基因分型试剂盒未检测到的 HPV 类型,以及(ii)确定这些类型在南非 HIV 感染女性队列中是否普遍存在。
从 109 例南非 HIV + 女性的宫颈标本中提取总 DNA。从 Roche Linear Array HPV 基因分型(LA)试剂盒检测到 12 种 HPV 基因型的 HIV + 女性队列中,选择一个代表复杂多重 HPV 感染的标本进行下一代测序分析。通过提取 DNA 的滚环扩增后的 Illumina 测序,确定宫颈标本中存在的所有 HPV 类型。然后,通过特定类型的 PCR 确定在 109 例 HIV 阳性南非女性中测序鉴定但未包含在 Roche LA 中的 HPV 类型的流行率。
Illumina 测序共在选定标本中鉴定出 16 种 HPV 基因型,其中 4 种基因型(HPV-30、74、86 和 90)未包含在商业试剂盒中。在 109 例 HIV 阳性南非女性中,HPV-30、74、86 和 90 的流行率分别为 14.6%、12.8%、4.6%和 8.3%。
我们的研究结果表明,在使用商业试剂盒进行分子流行病学研究时,HIV 阳性女性中存在具有相当流行率的 HPV 类型未被检测到。这些类型与宫颈疾病的关系仍有待研究。